Sensei Biotherapeutics, Inc. (SNSE) earnings
SNSE earnings moved a median of -2.42% by the close. Quarterly and annual SNSE reports and results, each read against the price at its own news timestamp. Back to the SNSE overview →
20 measured SNSE earnings events.
Where these SNSE earnings landedvs 20 measured SNSE earnings reactions
| Middle 50% of SNSE earnings reactions | -7.97% to +4.24% |
|---|---|
| Median reaction (to close) | -2.42% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 SNSE earnings events with a measured close landed between -7.97% and +4.24%; 40% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K/A Sensei Biotherapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.24% | -21.68% | |
| Form 10-Q Sensei Biotherapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +4.24% | |
| Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | +0.00% | +4.24% | |
| Form 10-K Sensei Biotherapeutics, For: Dec 31 | SEC filing · Form 10-K | +9.89% | +31.83% | |
| Form 10-Q Sensei Biotherapeutics, For: Sep 30 | SEC filing · Form 10-Q | — | -10.76% | |
| Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results | Press release | — | -10.76% | |
| Form 10-Q Sensei Biotherapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -5.95% | |
| Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | — | -2.84% | |
| Form 10-Q Sensei Biotherapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.03% | -2.00% | |
| Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress | Press release | +12.06% | +10.39% | |
| Form 10-K Sensei Biotherapeutics, For: Dec 31 | SEC filing · Form 10-K | +5.51% | +3.73% | |
| Form 10-Q Sensei Biotherapeutics, For: Sep 30 | SEC filing · Form 10-Q | -4.04% | -7.60% | |
| Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights | Press release | -4.04% | -7.60% | |
| Form 10-Q Sensei Biotherapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.15% | +3.71% | |
| Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights | Press release | — | +6.56% | |
| Form 10-Q Sensei Biotherapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.63% | -5.63% | |
| Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights | Press release | -5.93% | -19.07% | |
| Form 10-K Sensei Biotherapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.16% | |
| Form 10-Q Sensei Biotherapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.58% | +18.59% | |
| Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights | Press release | -2.00% | -9.07% |
Keep exploring
More SNSE: analyst actions → · SEC filings → · SNSE overview →